These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 22317867)
1. Aberrant expression of WWOX protein in epithelial ovarian cancer: a clinicopathologic and immunohistochemical study. Lan C; Chenggang W; Yulan B; Xiaohui D; Junhui Z; Xiao W Int J Gynecol Pathol; 2012 Mar; 31(2):125-32. PubMed ID: 22317867 [TBL] [Abstract][Full Text] [Related]
2. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. Nunez MI; Rosen DG; Ludes-Meyers JH; Abba MC; Kil H; Page R; Klein-Szanto AJ; Godwin AK; Liu J; Mills GB; Aldaz CM BMC Cancer; 2005 Jun; 5():64. PubMed ID: 15982416 [TBL] [Abstract][Full Text] [Related]
3. [Effects of WWOX gene transfection on cell growth of epithelial ovarian cancer]. Yan HC; Xue JQ; Lu XY; Wan MR; Feng X; Liu XY Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):361-5. PubMed ID: 18953870 [TBL] [Abstract][Full Text] [Related]
4. WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response. Janczar S; Nautiyal J; Xiao Y; Curry E; Sun M; Zanini E; Paige AJ; Gabra H Cell Death Dis; 2017 Jul; 8(7):e2955. PubMed ID: 28749468 [TBL] [Abstract][Full Text] [Related]
5. WWOX regulates the Elf5/Snail1 pathway to affect epithelial-mesenchymal transition of ovarian carcinoma cells in vitro. Xu Y; Yan YC; Hu YK; Fang LS; Li Q; Xu J; Yan HC Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1041-1053. PubMed ID: 32096174 [TBL] [Abstract][Full Text] [Related]
6. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077 [TBL] [Abstract][Full Text] [Related]
7. WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear. Gourley C; Paige AJW; Taylor KJ; Scott D; Francis NJ; Rush R; Aldaz CM; Smyth JF; Gabra H Int J Oncol; 2005 Jun; 26(6):1681-1689. PubMed ID: 15870886 [TBL] [Abstract][Full Text] [Related]
8. WWOX CNV-67048 Functions as a Risk Factor for Epithelial Ovarian Cancer in Chinese Women by Negatively Interacting with Oral Contraceptive Use. Chen Y; Tan X; Ding Y; Mai B; Huang X; Hu G; Luo X Biomed Res Int; 2016; 2016():6594039. PubMed ID: 27190995 [TBL] [Abstract][Full Text] [Related]
9. [Expression of Notch1, Jagged1 and NICD in epithelial ovarian carcinomas and a preliminary study on the activity of gamma-secretase in epithelial ovarian carcinoma cell lines]. Feng Z; Wen H; Liao Q Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):780-6. PubMed ID: 25537253 [TBL] [Abstract][Full Text] [Related]
10. Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status. Nunez MI; Ludes-Meyers J; Abba MC; Kil H; Abbey NW; Page RE; Sahin A; Klein-Szanto AJ; Aldaz CM Breast Cancer Res Treat; 2005 Jan; 89(2):99-105. PubMed ID: 15692750 [TBL] [Abstract][Full Text] [Related]
11. Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations. Maeda N; Semba S; Nakayama S; Yanagihara K; Yokozaki H Virchows Arch; 2010 Oct; 457(4):423-32. PubMed ID: 20737170 [TBL] [Abstract][Full Text] [Related]
12. Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis. He L; He J; Zhao X Asia Pac J Clin Oncol; 2016 Mar; 12(1):e161-6. PubMed ID: 23915006 [TBL] [Abstract][Full Text] [Related]
13. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
14. Decreased expression of WWOX in the development of esophageal squamous cell carcinoma. Guo W; Wang G; Dong Y; Guo Y; Kuang G; Dong Z Mol Carcinog; 2013 Apr; 52(4):265-74. PubMed ID: 22213016 [TBL] [Abstract][Full Text] [Related]
15. WWOX, a new potential tumor suppressor gene. Hezova R; Ehrmann J; Kolar Z Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):11-5. PubMed ID: 17690733 [TBL] [Abstract][Full Text] [Related]
16. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer. Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869 [TBL] [Abstract][Full Text] [Related]
17. Expression of deleted in liver cancer 1 and plasminogen activator inhibitor 1 protein in ovarian carcinoma and their clinical significance. Ren F; Shi H; Zhang G; Zhang R J Exp Clin Cancer Res; 2013 Aug; 32(1):60. PubMed ID: 23988121 [TBL] [Abstract][Full Text] [Related]
18. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]. Gao GL; Liu LD; Zou XS; Chen WX Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419 [TBL] [Abstract][Full Text] [Related]
19. WWOX, a chromosomal fragile site gene and its role in cancer. Ramos D; Aldaz CM Adv Exp Med Biol; 2006; 587():149-59. PubMed ID: 17163164 [TBL] [Abstract][Full Text] [Related]
20. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]